These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3037172)

  • 21. The effect of ACE inhibitors and atrial natriuretic factor on the cardiorenal axis in man.
    Struthers AD
    Br J Clin Pharmacol; 1992 Jul; 34(1):21-4. PubMed ID: 1385970
    [No Abstract]   [Full Text] [Related]  

  • 22. [Renal function during treatment with angiotensin converting enzyme inhibitors].
    Rasmussen K; Heitmann M; Nielsen JI; Møgelvang JC
    Ugeskr Laeger; 1995 Sep; 157(39):5377-81. PubMed ID: 7483049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
    Bauer WR; Neubauer S; Obitz G; Ertl G
    J Mol Cell Cardiol; 1994 Apr; 26(4):527-37. PubMed ID: 8072008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heart failure, renal function, and angiotensin converting enzyme inhibitors.
    Cleland JG; Dargie HJ
    Kidney Int Suppl; 1987 May; 20():S220-8. PubMed ID: 3037173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal effects of angiotensin-I converting enzyme inhibitors.
    Gans RO; Hoorntje SJ; Donker AJ
    Neth J Med; 1988 Jun; 32(5-6):247-64. PubMed ID: 3292962
    [No Abstract]   [Full Text] [Related]  

  • 27. [A 100-year perspective on renal function and hypertension. Anti-renin therapy has made hypertensive renal failure a rarity].
    Bergström G; Herlitz H; Himmelmann A; Ljungman S; Aurell M
    Lakartidningen; 1999 Nov; 96(47):5209-14. PubMed ID: 10608112
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
    Burnier M; Brunner HR
    Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Converting enzyme inhibition: implications for renal perfusion and function.
    Hollenberg NK
    Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Renal tissue angiotensins during converting enzyme inhibition of angiotensin I in spontaneously hypertensive rat].
    Ingert C; Grima M; Michel B; Barthelmebs M; Imbs JL
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1135-41. PubMed ID: 9404423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renin-angiotensin blockade improves renal cGMP production via non-AT(2)-receptor mediated mechanisms in hypertension-induced by chronic NOS inhibition in rat.
    Uhlenius N; Vuolteenaho O; Tikkanen I
    J Renin Angiotensin Aldosterone Syst; 2001 Dec; 2(4):233-9. PubMed ID: 11881129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin converting enzyme inhibitor-induced renal dysfunction: recommendations for prevention.
    Cooke HM; De Besse A
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):65-70. PubMed ID: 8004361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of alatriopril, a mixed inhibitor of atriopeptidase and angiotensin I-converting enzyme, on cardiac hypertrophy and hormonal responses in rats with myocardial infarction. Comparison with captopril.
    Bralet J; Marie C; Mossiat C; Lecomte JM; Gros C; Schwartz JC
    J Pharmacol Exp Ther; 1994 Jul; 270(1):8-14. PubMed ID: 8035346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.
    Hollenberg NK
    J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S239-42. PubMed ID: 9892171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natriuretic peptides: biochemistry, physiology, and therapeutic role in heart failure.
    Stoupakis G; Klapholz M
    Heart Dis; 2003; 5(3):215-23. PubMed ID: 12783635
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Angiotensin-converting enzyme inhibitors: effects on renal physiology and applications in hypertension and renal disease].
    Cofán F; Romero R
    Rev Clin Esp; 1993 Jan; 192(1):31-8. PubMed ID: 8465029
    [No Abstract]   [Full Text] [Related]  

  • 37. Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure.
    Chee KH; Amudha K; Hussain NA; Haizal HK; Choy AM; Lang CC
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):140-8. PubMed ID: 14608517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combined angiotensin-converting enzyme inhibition and adrenomedullin in an ovine model of heart failure.
    Rademaker MT; Charles CJ; Cooper GJ; Coy DH; Espiner EA; Lewis LK; Nicholls MG; Richards AM
    Clin Sci (Lond); 2002 Jun; 102(6):653-60. PubMed ID: 12049620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibitors of the renin-angiotensin system.
    Brunner HR; Nussberger J; Waeber B
    Arzneimittelforschung; 1993 Feb; 43(2A):274-8. PubMed ID: 8498978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human atrial natriuretic peptide, renal function, and cardiac surgery: do we all read the same?
    Lema G
    Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):138-9. PubMed ID: 19471232
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.